Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma
INTRODUCTION: Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784422/ https://www.ncbi.nlm.nih.gov/pubmed/31624460 http://dx.doi.org/10.11613/BM.2019.030707 |
_version_ | 1783457754462027776 |
---|---|
author | Lopez, Benjamin Bertier, Nicolas Ledoult, Emmanuel Joudinaud, Romane Maanaoui, Mehdi Majerus, Victoria Moitrot, Emmanuelle Deleplancque, Anne-Sophie Rogeau, Stéphanie Launay, David Lefèvre, Guillaume Labalette, Myriam Dubucquoi, Sylvain |
author_facet | Lopez, Benjamin Bertier, Nicolas Ledoult, Emmanuel Joudinaud, Romane Maanaoui, Mehdi Majerus, Victoria Moitrot, Emmanuelle Deleplancque, Anne-Sophie Rogeau, Stéphanie Launay, David Lefèvre, Guillaume Labalette, Myriam Dubucquoi, Sylvain |
author_sort | Lopez, Benjamin |
collection | PubMed |
description | INTRODUCTION: Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess the need for age-specific RIs in EDTA plasma. MATERIALS AND METHODS: We retrospectively evaluated a cohort of 387 patients attending our university hospital and known to be free of complement-modifying diseases. The need for age partitioning was assessed and RIs were calculated according to the CLSI protocol. RESULTS: No need for age partitioning was evidenced for CP50 activity, C3c and C4 concentrations and RIs (90% CI) were calculated from the pooled data: 35.4 (33.1-37.2) to 76.3 (73.7-83.6) U/mL for CP50 activity, 0.80 (0.75-0.87) to 1.64 (1.59-1.72) g/L for C3c, and 0.12 (0.10-0.14) to 0.38 (0.36-0.40) g/L for C4. Our results highlight a positive association between age and C1INH concentrations. We derived 3 age partitions (6 months to 30 years, 30-50 and > 50 years) and the related RIs: 0.20 (0.18-0.21) to 0.38 (0.36-0.40) g/L, 0.22 (0.20-0.24) to 0.39 (0.36-0.41) g/L and 0.25 (0.22-0.27) to 0.41 (0.40-0.43) g/L, respectively). CONCLUSIONS: The newly determined RIs for CP50 activity were higher than those provided by the manufacturer for EDTA plasma samples, whereas those for C3c and C4 RIs were similar to the values provided for serum samples. The C1INH concentration and activity were found to be associated with age and age-specific RIs are mandatory for this analyte. |
format | Online Article Text |
id | pubmed-6784422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Croatian Society of Medical Biochemistry and Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-67844222019-10-17 Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma Lopez, Benjamin Bertier, Nicolas Ledoult, Emmanuel Joudinaud, Romane Maanaoui, Mehdi Majerus, Victoria Moitrot, Emmanuelle Deleplancque, Anne-Sophie Rogeau, Stéphanie Launay, David Lefèvre, Guillaume Labalette, Myriam Dubucquoi, Sylvain Biochem Med (Zagreb) Original Articles INTRODUCTION: Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess the need for age-specific RIs in EDTA plasma. MATERIALS AND METHODS: We retrospectively evaluated a cohort of 387 patients attending our university hospital and known to be free of complement-modifying diseases. The need for age partitioning was assessed and RIs were calculated according to the CLSI protocol. RESULTS: No need for age partitioning was evidenced for CP50 activity, C3c and C4 concentrations and RIs (90% CI) were calculated from the pooled data: 35.4 (33.1-37.2) to 76.3 (73.7-83.6) U/mL for CP50 activity, 0.80 (0.75-0.87) to 1.64 (1.59-1.72) g/L for C3c, and 0.12 (0.10-0.14) to 0.38 (0.36-0.40) g/L for C4. Our results highlight a positive association between age and C1INH concentrations. We derived 3 age partitions (6 months to 30 years, 30-50 and > 50 years) and the related RIs: 0.20 (0.18-0.21) to 0.38 (0.36-0.40) g/L, 0.22 (0.20-0.24) to 0.39 (0.36-0.41) g/L and 0.25 (0.22-0.27) to 0.41 (0.40-0.43) g/L, respectively). CONCLUSIONS: The newly determined RIs for CP50 activity were higher than those provided by the manufacturer for EDTA plasma samples, whereas those for C3c and C4 RIs were similar to the values provided for serum samples. The C1INH concentration and activity were found to be associated with age and age-specific RIs are mandatory for this analyte. Croatian Society of Medical Biochemistry and Laboratory Medicine 2019-10-15 2019-10-15 /pmc/articles/PMC6784422/ /pubmed/31624460 http://dx.doi.org/10.11613/BM.2019.030707 Text en ©Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Lopez, Benjamin Bertier, Nicolas Ledoult, Emmanuel Joudinaud, Romane Maanaoui, Mehdi Majerus, Victoria Moitrot, Emmanuelle Deleplancque, Anne-Sophie Rogeau, Stéphanie Launay, David Lefèvre, Guillaume Labalette, Myriam Dubucquoi, Sylvain Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma |
title | Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma |
title_full | Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma |
title_fullStr | Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma |
title_full_unstemmed | Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma |
title_short | Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma |
title_sort | classical pathway activity c3c, c4 and c1-inhibitor protein reference intervals determination in edta plasma |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784422/ https://www.ncbi.nlm.nih.gov/pubmed/31624460 http://dx.doi.org/10.11613/BM.2019.030707 |
work_keys_str_mv | AT lopezbenjamin classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT bertiernicolas classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT ledoultemmanuel classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT joudinaudromane classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT maanaouimehdi classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT majerusvictoria classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT moitrotemmanuelle classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT deleplancqueannesophie classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT rogeaustephanie classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT launaydavid classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT lefevreguillaume classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT labalettemyriam classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma AT dubucquoisylvain classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma |